CRYSTAL ROGER 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
CRYSTAL ROGER
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2023-01-27$20.26/sh−1,358$27,513→ 75,339 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.